PFM Health Sciences’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-411,727
| Closed | -$7.35M | – | 69 |
|
|
2020
Q2 | $7.35M | Sell |
411,727
-62,328
| -13% | -$1.11M | 0.38% | 57 |
|
|
2020
Q1 | $7.69M | Sell |
474,055
-61,031
| -11% | -$990K | 0.63% | 48 |
|
|
2019
Q4 | $9.63M | Sell |
535,086
-154,739
| -22% | -$2.79M | 0.46% | 45 |
|
|
2019
Q3 | $14M | Sell |
689,825
-768,160
| -53% | -$15.6M | 0.41% | 52 |
|
|
2019
Q2 | $32.2M | Buy |
1,457,985
+510,924
| +54% | +$11.3M | 0.61% | 48 |
|
|
2019
Q1 | $12.9M | Buy |
+947,061
| New | +$12.9M | 0.29% | 68 |
|
|
2017
Q3 | – | Sell |
-1,802,611
| Closed | -$25.9M | – | 86 |
|
|
2017
Q2 | $25.9M | Buy |
1,802,611
+302,929
| +20% | +$4.35M | 0.7% | 46 |
|
|
2017
Q1 | $31.7M | Buy |
+1,499,682
| New | +$31.7M | 0.79% | 49 |
|
|
2016
Q1 | – | Sell |
-172,638
| Closed | -$3.96M | – | 76 |
|
|
2015
Q4 | $3.96M | Sell |
172,638
-122,941
| -42% | -$2.82M | 0.12% | 60 |
|
|
2015
Q3 | $5.92M | Buy |
295,579
+7,500
| +3% | +$150K | 0.17% | 59 |
|
|
2015
Q2 | $8.33M | Buy |
+288,079
| New | +$8.33M | 0.21% | 69 |
|